Assembly Biosciences, Inc. (ASMB)
USD 13.51
(-5.39%)
USD 13.51
(-5.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.16 Million | - | 6.25 Million | 79.1 Million | 15.96 Million | 14.8 Million |
| Cost of Revenue | 48.9 Million | 498 Thousand | 466 Thousand | 101.33 Thousand | 85.32 Thousand | 72.74 Million |
| Gross Profit | -41.73 Million | -498 Thousand | 5.78 Million | 79 Million | 15.87 Million | -57.93 Million |
| Operating Expenses | 22.9 Million | 94.11 Million | 97.3 Million | 143.88 Million | 118.67 Million | 107.53 Million |
| Selling, General and Administrative Expenses | 22.9 Million | 24.13 Million | 28.78 Million | 37.05 Million | 32.91 Million | 34.79 Million |
| Research and Development Expenses | 48.9 Million | 69.98 Million | 68.52 Million | 106.82 Million | 85.75 Million | 72.74 Million |
| Other Expenses | - | - | 41.63 Million | - | 5000.00 | - |
| Cost and Expenses | 71.8 Million | 94.11 Million | 97.3 Million | 143.88 Million | 118.67 Million | 107.53 Million |
| Operating Income | -64.64 Million | -94.11 Million | -132.68 Million | -64.77 Million | -102.71 Million | -92.73 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 33 Thousand | -1.02 Million | -2.53 Million | -2.62 Million | -774 Thousand | 1.09 Million |
| Earnings before Tax | -61.19 Million | -93.09 Million | -132.38 Million | -62.15 Million | -98.4 Million | -89.65 Million |
| Net Income | -61.22 Million | -92.07 Million | -129.85 Million | -59.52 Million | -97.63 Million | -90.75 Million |
| Earnings Per Share Basic | -13.38 | -22.82 | -2.79 | -1.50 | -2.78 | -3.98 |
| Earnings Per Share Diluted | -13.38 | -22.82 | -2.77 | -1.50 | -2.78 | -3.98 |
| Weighted Average Shares Outstanding | 4.57 Million | 4.03 Million | 46.53 Million | 39.67 Million | 35.07 Million | 22.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.57 Million | 4.03 Million | 46.84 Million | 39.67 Million | 35.07 Million | 22.8 Million |
| Gross Margin | -5.83 | - | 0.93 | 1.00 | 0.99 | -3.91 |
| EBIT Margin | -8.96 | - | -7.90 | -0.81 | -6.43 | -6.22 |
| Profit Margin | -8.55 | - | -20.76 | -0.75 | -6.12 | -6.13 |
| EBITDA | -64.19 Million | -92.59 Million | -91.93 Million | -64.77 Million | -102.71 Million | -92.73 Million |
| Earnings Before Tax Margin | -9.02 | - | -21.22 | -0.82 | -6.43 | -6.26 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.53 Million | 5.78 Million | 7.16 Million | 7.16 Million | - | - |
| Cost of Revenue | 32 Thousand | 32 Thousand | 450 Thousand | 84 Thousand | 116 Thousand | 126 Thousand |
| Gross Profit | 8.5 Million | 5.75 Million | 6.71 Million | 7.07 Million | -116 Thousand | -126 Thousand |
| Operating Expenses | 20.7 Million | 16.48 Million | 71.35 Million | 19.63 Million | 15.04 Million | 17.48 Million |
| Selling, General and Administrative Expenses | 4.44 Million | 4.6 Million | - | 8.62 Million | 4.22 Million | 4.96 Million |
| Research and Development Expenses | 16.25 Million | 11.87 Million | - | 11 Million | 10.82 Million | 12.52 Million |
| Other Expenses | -16.25 Million | - | - | - | - | - |
| Cost and Expenses | 20.73 Million | 16.51 Million | 71.8 Million | 19.71 Million | 15.04 Million | 17.48 Million |
| Operating Income | -12.2 Million | -10.72 Million | -64.64 Million | -12.55 Million | -15.04 Million | -17.48 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 406 Thousand | -11.27 Thousand | 33 Thousand | 33 Thousand | -116 Thousand | 3915.00 |
| Earnings before Tax | -10.74 Million | -9.07 Million | -61.19 Million | -10.92 Million | -14.42 Million | -16.89 Million |
| Net Income | -11.15 Million | -9.07 Million | -61.22 Million | -10.96 Million | -14.42 Million | -16.89 Million |
| Earnings Per Share Basic | -1.98 | -1.66 | - | -2.00 | -3.29 | -3.88 |
| Earnings Per Share Diluted | -1.98 | -1.66 | - | -2.00 | -3.29 | -3.88 |
| Weighted Average Shares Outstanding | 5.64 Million | 5.48 Million | 4.57 Million | 5.48 Million | 4.38 Million | 4.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.64 Million | 5.48 Million | 4.57 Million | 5.48 Million | 4.38 Million | 4.35 Million |
| Gross Margin | 1.00 | 0.99 | 0.94 | 0.99 | - | - |
| EBIT Margin | -1.43 | -1.85 | - | -1.74 | - | - |
| Profit Margin | -1.31 | -1.57 | -8.55 | -1.53 | - | - |
| EBITDA | -12.17 Million | -10.69 Million | - | -12.46 Million | -15.04 Million | -17.36 Million |
| Earnings Before Tax Margin | -1.43 | -1.85 | -9.02 | -1.75 | - | - |
PBCO
7844
6661
CNRFF
VLGEA
CTAGF